Synthekine Expands Board of Directors, Management Team and Scientific Advisory Board with New Key Appointments

MENLO PARK, Calif.--(BUSINESS WIRE)--Synthekine Inc., an engineered cytokine therapeutics company, today announced that it has appointed Mardi Dier to its board of directors, Robin Knifsend as senior vice president of finance and operations and Antoni Ribas, M.D., Ph.D., to its scientific advisory board. Ms. Dier is the CFO and executive...

Click to view original post